Fluconazole/ Azithromycin / Secnidazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 150mg + 1 gm + 1 gm
Reference Brands: FAS Trio (India), Fluco-Azi-Sec (India), FAS Triple (LATAM)
Category:
Antibiotics
Used for the treatment of Respiratory Tract Infections, Vaginal Infections, Fungal Infections, Urethra Infection, Intestinal Amoebiasis, Liver Infection and other conditions.
Trio Kit contains Azithromycin, Fluconazole, and Secnidazole as active ingredients.
Trio Kit works by inhibiting energy production of the disease; inhibiting the growth of fungi; killing bacteria and preventing them from reproducing;
Product Description:
Trio Kit improves the patient's condition by performing the following functions: · Inhibiting energy production of the disease. · Inhibiting the growth of fungi. · Killing bacteria and preventing them from reproducing.
Fluconazole / Azithromycin / Secnidazole tablets are a combination therapy designed to treat mixed bacterial, protozoal, and fungal infections. This triple-drug formulation is particularly useful for conditions where infections are caused by multiple pathogens simultaneously, such as certain vaginal infections, gastrointestinal infections, and sexually transmitted infections.
Fluconazole is a triazole antifungal that works by inhibiting the synthesis of fungal cell membranes, effectively stopping fungal growth. Azithromycin is a macrolide antibiotic that prevents bacterial protein synthesis, targeting a broad spectrum of Gram-positive and Gram-negative bacteria. Secnidazole is a nitroimidazole antimicrobial effective against anaerobic bacteria and protozoa, disrupting their DNA and inhibiting replication.
The combination tablet provides a convenient single-dose regimen, improving patient compliance and ensuring comprehensive treatment of mixed infections. This formulation is especially beneficial in regions with higher prevalence of co-infections, where simultaneous coverage against bacteria, fungi, and protozoa is required. Manufactured by several pharmaceutical companies in India, Southeast Asia, Latin America, and other global markets, these tablets are widely used for effective eradication of mixed infections while minimizing the need for multiple medications.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing